IBM has built a new drug-making lab entirely in the cloud

The news: IBM has built a new chemistry lab called RoboRXN in the cloud. It combines AI models, a cloud computing platform, and robots to help scientists design and synthesize new molecules while working from home.

How it works: The online lab platform allows scientists to log on through a web browser. On a blank canvas, they draw the skeletal structure of the molecular compounds they want to make, and the platform uses machine learning to predict the ingredients required and the order in which they should be mixed. It then sends the instructions to a robot in a remote lab to execute. Once the experiment is done, the platform sends a report to the scientists with the results.

A screenshot of IBM's RoboRXN platform, which lets scientists draw the skeletal structure of the molecular compounds they want to make.
The online platform lets scientists draw the skeletal structure of the molecular compounds they want to make.

IBM RESEARCH

Why it matters: New drugs and materials traditionally require an average of

Read More